Maria Seifer

2.1k total citations
39 papers, 1.5k citations indexed

About

Maria Seifer is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Maria Seifer has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 24 papers in Hepatology and 16 papers in Infectious Diseases. Recurrent topics in Maria Seifer's work include Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (24 papers) and HIV/AIDS drug development and treatment (13 papers). Maria Seifer is often cited by papers focused on Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (24 papers) and HIV/AIDS drug development and treatment (13 papers). Maria Seifer collaborates with scholars based in United States, Germany and France. Maria Seifer's co-authors include David N. Standring, Wolfram H. Gerlich, Richard J. Colonno, Stephan Schaefer, Martin Höhne, Steven Innaimo, Robert Hamatake, Gregory S. Bisacchi, Robert Zahler and Mark A. Feitelson and has published in prestigious journals such as The EMBO Journal, Hepatology and Journal of Virology.

In The Last Decade

Maria Seifer

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Seifer United States 19 1.2k 868 424 318 180 39 1.5k
Jin-Hua Sun United States 24 1.0k 0.8× 1.3k 1.5× 607 1.4× 427 1.3× 166 0.9× 34 2.0k
Kenneth Simmen Belgium 20 892 0.7× 753 0.9× 459 1.1× 450 1.4× 83 0.5× 39 1.6k
Peter W. White Canada 21 576 0.5× 454 0.5× 287 0.7× 417 1.3× 219 1.2× 46 1.3k
Tsuyoshi Adachi Japan 12 406 0.3× 694 0.8× 305 0.7× 370 1.2× 177 1.0× 20 1.2k
Magdeleine Hung United States 21 520 0.4× 315 0.4× 622 1.5× 456 1.4× 93 0.5× 38 1.4k
Xuanyong Lu United States 16 473 0.4× 319 0.4× 145 0.3× 246 0.8× 103 0.6× 26 781
Jan Martin Berke Belgium 16 712 0.6× 764 0.9× 340 0.8× 183 0.6× 54 0.3× 31 1.0k
Linda Bartholomew Italy 11 505 0.4× 668 0.8× 364 0.9× 237 0.7× 46 0.3× 14 962
Tony Whitaker United States 17 410 0.3× 436 0.5× 555 1.3× 324 1.0× 192 1.1× 36 1.0k
Séverine Carrère‐Kremer France 17 385 0.3× 173 0.2× 264 0.6× 242 0.8× 266 1.5× 23 876

Countries citing papers authored by Maria Seifer

Since Specialization
Citations

This map shows the geographic impact of Maria Seifer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Seifer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Seifer more than expected).

Fields of papers citing papers by Maria Seifer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Seifer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Seifer. The network helps show where Maria Seifer may publish in the future.

Co-authorship network of co-authors of Maria Seifer

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Seifer. A scholar is included among the top collaborators of Maria Seifer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Seifer. Maria Seifer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alexandre, François-René, Catherine Caillet, Thierry Convard, et al.. (2015). Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease. Bioorganic & Medicinal Chemistry Letters. 25(18). 3984–3991. 8 indexed citations
2.
Chapron, Christopher, Rebecca Glen, Massimiliano La Colla, et al.. (2014). Synthesis of 2′-O,4′-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 24(12). 2699–2702. 10 indexed citations
3.
McCarville, Joseph, Maria Seifer, David N. Standring, & Douglas L. Mayers. (2013). 1209 TREATMENT-EMERGENT VARIANTS FOLLOWING 3 DAYS OF MONOTHERAPY WITH IDX719, A POTENT, PAN-GENOTYPIC NS5A INHIBITOR, IN SUBJECTS INFECTED WITH HCV GENOTYPES 1–4. Journal of Hepatology. 58. S491–S492. 4 indexed citations
4.
Dousson, Cyril B., Christopher Chapron, David N. Standring, et al.. (2011). 815 IDENIX NS5A HCV REPLICATION INHIBITORS WITH LOW PICOMOLAR, PAN-GENOTYPIC IN VITRO ANTIVIRAL ACTIVITY. Journal of Hepatology. 54. S326–S327. 7 indexed citations
5.
Bilello, John P., Massimiliano La Colla, Michel Liuzzi, et al.. (2009). 344 PRECLINICAL PROFILES OF IDX136 AND IDX316, TWO NOVEL MACROCYCLIC HCV PROTEASE INHIBITORS. Journal of Hepatology. 50. S132–S132. 1 indexed citations
6.
7.
Glebe, Dieter, Andreas Berting, Heike Naumann, et al.. (2001). Optimised Conditions for the Production of Hepatitis B Virus from Cell Culture. Intervirology. 44(6). 370–378. 17 indexed citations
8.
Genovesi, Eugene V., D. Taylor, Maria Seifer, et al.. (2000). Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection. Antiviral Research. 48(3). 197–203. 12 indexed citations
9.
Schaefer, Stephan, et al.. (1998). Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein.. Journal of General Virology. 79(4). 767–777. 21 indexed citations
10.
Seifer, Maria & David N. Standring. (1995). Ribonucleoprotein Complex Formation by the Human Hepatitis B Virus Polymerase. Intervirology. 38(5). 295–303. 3 indexed citations
11.
Seifer, Maria & David N. Standring. (1995). Assembly and Antigenicity of Hepatitis B Virus Core Particles. Intervirology. 38(1-2). 47–62. 36 indexed citations
12.
Seifer, Maria & David N. Standring. (1993). Stability Governs the Apparent Expression of "Particulate" Hepatitis B e Antigen by Mutant Hepatitis B Virus Core Particles. Virology. 196(1). 70–78. 9 indexed citations
13.
Seifer, Maria, Martin Höhne, Stephan Schaefer, & Wolfram H. Gerlich. (1991). In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. Journal of Hepatology. 13. S61–S65. 73 indexed citations
14.
Gerlich, Wolfram H., et al.. (1990). Protective potential of hepatitis B virus antigens other than the S gene protein. Vaccine. 8. S63–S68. 41 indexed citations
15.
Seifer, Maria, K.‐H. Heermann, & Wolfram H. Gerlich. (1990). Replication of hepatitis B virus in transfected nonhepatic cells. Virology. 179(1). 300–311. 23 indexed citations
16.
Seifer, Maria, K.‐H. Heermann, & Wolfram H. Gerlich. (1990). Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts. Virology. 179(1). 287–299. 17 indexed citations
17.
Krone, Bernd, et al.. (1990). Interaction Between Hepatitis B Surface Proteins and Monomeric Human Serum Albumin. Hepatology. 11(6). 1050–1056. 43 indexed citations
18.
Marquardt, Otfried, K.‐H. Heermann, Maria Seifer, & Wolfram H. Gerlich. (1987). Cell type specific expression of pre S 1 antigen and secretion of hepatitis B virus surface antigen. Archives of Virology. 96(3-4). 249–256. 18 indexed citations
19.
Heermann, Klaus‐Hinrich, et al.. (1987). Immunogenicity of the Gene S and Pre-S Domains in Hepatitis B Virions and HBsAg Filaments. Intervirology. 28(1). 14–25. 58 indexed citations
20.
Marquardt, Otfried, et al.. (1987). Cell-type dependent expression and secretion of hepatitis B virus pre-S1 surface antigen.. PubMed. 63 Suppl 2. 41–50. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin-Hua Sun Breakdown of academic impact, for papers by Kenneth Simmen Breakdown of academic impact, for papers by Peter W. White Breakdown of academic impact, for papers by Tsuyoshi Adachi Breakdown of academic impact, for papers by Magdeleine Hung Breakdown of academic impact, for papers by Xuanyong Lu Breakdown of academic impact, for papers by Jan Martin Berke Breakdown of academic impact, for papers by Linda Bartholomew Breakdown of academic impact, for papers by Tony Whitaker Breakdown of academic impact, for papers by Séverine Carrère‐Kremer
Rankless by CCL
2026